68Ga-FAPI-PET/CT检测的滑膜与附着点成纤维细胞活化与银屑病患者关节痛进展为银屑病关节炎相关
本研究纳入45例伴关节痛的银屑病患者,行68Ga-FAPI-PET/CT并前瞻性随访,37例(82%)为FAPI阳性。FAPI阳性与更高BMI、DAS28-CRP及低级别滑膜增生、附着点能量多普勒、合并骨关节炎相关,且进展为银屑病关节炎的风险更高(HR 7.1,95%CI 0.9-53.6;log-rank p=0.028)。
要点
- 伴关节痛的银屑病患者中82%存在68Ga-FAPI摄取,提示成纤维细胞活化。
- FAPI阳性与更高BMI、DAS28-CRP及超声亚临床改变相关。
- FAPI阳性者进展为银屑病关节炎风险更高(HR 7.1,log-rank p=0.028)。
核心结论
- 在伴关节痛的银屑病患者中,68Ga-FAPI摄取提示的成纤维细胞活化与更高BMI、更多疼痛、亚临床超声改变及合并骨关节炎相关。
- 关节部位病理性68Ga-FAPI摄取提示进展为银屑病关节炎的更高风险,提示成纤维细胞活化可能是发展为银屑病关节炎的关键步骤。
研究设计与样本
- 前瞻性队列研究,纳入45例伴关节痛的银屑病患者,行68Ga-FAPI-PET/CT并前瞻性随访。
- 在71个关节部位评估68Ga-FAPI摄取,至少1个关节有摄取且PET/CT关节指数≥2定义为FAPI阳性。
主要发现
- 45例中37例(82%)为FAPI阳性。
- FAPI阳性患者BMI(p=0.036)和DAS28-CRP(p=0.033)显著高于FAPI阴性患者。
- 68Ga-FAPI摄取最常见于大关节和机械应力部位,更常见于低级别滑膜增生(OR 1.77,95%CI 1.08-2.89)、附着点能量多普勒(OR 3.80,95%CI 1.66-8.72)及合并骨关节炎时。
- FAPI阳性患者进展为银屑病关节炎风险更高(HR 7.1,95%CI 0.9-53.6;log-rank p=0.028)。
- 无68Ga-FAPI摄取者中1/8(12.5%)进展为银屑病关节炎,FAPI阳性者中18/37(49%)进展。
关键数值与推荐
- FAPI阳性定义:至少1个关节有68Ga-FAPI摄取且PET/CT关节指数≥2。
- 进展为银屑病关节炎风险:FAPI阳性 vs 阴性 HR 7.1(95%CI 0.9-53.6),log-rank p=0.028。
临床怎么用
- 对伴关节痛的银屑病患者,68Ga-FAPI-PET/CT可检测亚临床成纤维细胞活化,辅助识别进展为银屑病关节炎的高风险者。
局限性
- 样本量较小(45例),进展为银屑病关节炎事件的置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the clinical and imaging characteristics associated with fibroblast activation detected by 68Gallium-labelled fibroblast activation protein inhibitor positron emission tomography/CT (68Ga-FAPI-PET/CT) in patients with psoriasis and whether 68Ga-FAPI uptake correlates with the risk of progression to psoriatic arthritis (PsA). METHODS: Psoriasis patients with arthralgia underwent 68Ga-FAPI-PET/CT and were followed up prospectively. 68Ga-FAPI uptake was assessed at 71 articular sites and patients with ≥1 joint with 68Ga-FAPI uptake and PET/CT Joint Index≥2 were considered FAPI positive. The associations between FAPI uptake and clinical and ultrasound (US) findings were investigated. Survival analyses were conducted to assess the association between 68Ga-FAPI uptake and progression to PsA. RESULTS: 45 patients with psoriasis were enrolled, 37 of whom (82%) were FAPI positive. FAPI-positive psoriasis patients had significantly higher body mass index (BMI) (p=0.036) and Disease Activity Score 28-C reactive protein (p=0.033) compared with FAPI-negative patients. 68Ga-FAPI uptake was most frequent in large joints and mechanically stressed sites and was more likely in the presence of low-grade synovial hyperplasia (OR: 1.77, 95% CI 1.08 to 2.89), entheseal Power Doppler (OR: 3.80, 95% CI 1.66 to 8.72) and concomitant osteoarthritis (OA). FAPI-positive patients showed a higher risk of progression to PsA compared with FAPI-negative patients (HR 7.1, 95% CI 0.9 to 53.6) (log-rank p=0.028). Only 1/8 patients with psoriasis (12.5%) without 68Ga-FAPI uptake developed PsA, as opposed to 18/37 (49%) of FAPI-positive patients. CONCLUSIONS: In psoriasis patients with arthralgia, 68Ga-FAPI uptake, indicating fibroblast activation, is associated with higher BMI, more pain, subclinical US changes and concomitant OA. Pathological 68Ga-FAPI uptake at articular sites was indicative of higher risk of progression to PsA in our cohort, suggesting fibroblast activation as a crucial step to develop PsA.
引用
- Corte G, Atzinger A, Noversa de Sousa R, et al. Increased synovial and entheseal fibroblast activation detected by 68Ga-FAPI-PET/CT is associated with the development of psoriatic arthritis in psoriasis patients with arthralgia. RMD Open. 2026. PMID: 41871918. doi:10.1136/rmdopen-2025-006567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。